Ticker League

Revolution Medicines (RVMD) Profit Bridge

See what drove Revolution Medicines's net income from TTM through Q1 2025 to TTM through Q1 2026 — every line ranked by dollar impact, from revenue gains to taxes.

TTM

Revenue YoY

Operating Income YoY

-75.68%

Net Income YoY

-96.70%

Net Margin Δ

Net income bridge for Revolution Medicines (RVMD) — TTM through Q1 2026 vs TTM through Q1 2025

Δ Net income: −$674.20M-96.70%

Profit bridge breakdown for Revolution Medicines (RVMD) — TTM through Q1 2026 vs TTM through Q1 2025

  • Prior Net Income−$697.51M
  • Revenue$0.00
  • Cost of Revenue−$9.24M
  • Operating Expenses−$588.17M
  • Other Income / Expense−$76.04M
  • Income Tax−$753.00K
  • Net Loss−$1.37B
Identity check: drivers reconcile to ΔNI within $0.00
Want the full P&L structure?Income Statement Waterfall

Frequently asked questions

Data & methodology

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation